Home›Companies›Biotech & Pharma›DepYmed

DepYmed Inc.

Updated Oct 29, 2026·Latest SEC filing Apr 25, 2025·Suggest an edit

About DepYmed

DepYmed is a private company based in Farmingdale, New York. It has reported $9,150,000 raised in six offerings on Form D since April 2021. Its chief executive is Andreas Grill.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 9, 2025Apr 25, 2025$250,000fully sold1$250KEquity, Securities on exerciseRule 506(b)Form D ↗
Jan 29, 2025Feb 11, 2025$250,000fully sold1$250KEquity, Securities on exerciseRule 506(b)Form D ↗
Aug 12, 2024Aug 16, 2024$600,000fully sold2$300KEquityRule 506(b)Form D ↗
Mar 6, 2024Mar 12, 2024$500,000fully sold2$250KEquityRule 506(b)Form D ↗
Mar 27, 2023May 4, 2023$2,000,000fully sold2$1.0MEquity, Securities on exerciseRule 506(b)Form D ↗
Apr 1, 2021Apr 7, 2021$5,550,000of $15.0M target3$1.8MEquity, Securities on exerciseRule 506(b)Form D ↗
Total, six offerings$9,150,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on DepYmed's Form D filed Apr 25, 2025.

LG
Leo Guthart
Director
SW
Steve Winick
Director
PY
Peter Young
Director
AG
Andreas Grill
President & Chief Executive Officer, director

Earlier filings also listed Peter Van Ness (executive officer, last listed Mar 2024) and Samuel Backenroth (director, last listed Apr 2021).

Sources

  1. SECDepYmed Inc. filing history